{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T14:23:55Z","timestamp":1748442235689},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1994,9,1]],"date-time":"1994-09-01T00:00:00Z","timestamp":778377600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[1994,9]]},"DOI":"10.1007\/bf02242937","type":"journal-article","created":{"date-parts":[[2005,11,15]],"date-time":"2005-11-15T04:07:29Z","timestamp":1132027649000},"page":"427-432","source":"Crossref","is-referenced-by-count":14,"title":["Clinical correlation of anticentromere antibodies"],"prefix":"10.1007","volume":"13","author":[{"given":"M.","family":"Zuber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Gotzen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Filler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02242937_CR1","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0065-2776(08)60641-0","volume":"44","author":"E.M. Tan","year":"1989","unstructured":"Tan, E.M. Antinuclear antibodies: Diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol 1989, 44, 93\u2013151.","journal-title":"Adv Immunol"},{"key":"BF02242937_CR2","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0090-1229(88)90066-9","volume":"47","author":"E.M. Tan","year":"1988","unstructured":"Tan, E.M., Chan, E.K.L., Sullivan, K.F., Rubin, R.I. Antinuclear antibodies (ANAs): Diagnostically specific immune markers and clues toward the understanding of systemic autoimmunity. Clin Immunol Immunopath 1988, 47, 121\u2013141.","journal-title":"Clin Immunol Immunopath"},{"key":"BF02242937_CR3","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1073\/pnas.77.3.1627","volume":"77","author":"Y. Moroi","year":"1980","unstructured":"Moroi, Y., Peebles, C., Fritzler, M.J., Steigerwald, J., Tan, E.M. Autoantibody to centromere (kinetochore) in scleroderma sera. Proc Natl Acad Sci USA 1980, 77, 1627\u20131631.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF02242937_CR4","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/art.1780230602","volume":"23","author":"E.M. Tan","year":"1980","unstructured":"Tan, E.M., Rodnan, G.P., Garcia, I., Moroi, Y., Fritzler, M.J., Peebles, C. Diversity of antinuclear antibodies in progressive systemic sclerosis: anti-centromere antibody and its relationship to CREST syndrome. Arthritis Rheum 1980, 23, 617\u2013625.","journal-title":"Arthritis Rheum"},{"key":"BF02242937_CR5","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/0002-9343(80)90462-3","volume":"69","author":"M.J. Fritzler","year":"1980","unstructured":"Fritzler, M.J., Kinsella, T.D., Garbutt, E. The CREST syndrome: A distinct serologic entity with anticentromere antibodies. Am J Med 1980, 69, 520\u2013526.","journal-title":"Am J Med"},{"key":"BF02242937_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.1780260101","volume":"26","author":"G.A. McCarty","year":"1983","unstructured":"McCarty, G.A., Rice, J.R., Bembe, M.L., Barada, Jr. Fa. Anticentromere antibody. Clinical correlations and association with favorable prognosis in patients with scleroderma variants. Arthritis Rheum 1983, 26, 1\u20137.","journal-title":"Arthritis Rheum"},{"key":"BF02242937_CR7","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/S0025-6196(12)62059-X","volume":"59","author":"F.A. Powell","year":"1984","unstructured":"Powell, F.A., Winkelmann, R.K., Venencie-Lemarchand, F., Spurbeck, J.L., Schroeter A.L. The anticentromere antibody. Disease specificity and clinical significance. Mayo Clin Proc 1984, 59, 700\u2013706.","journal-title":"Mayo Clin Proc"},{"key":"BF02242937_CR8","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1365-2133.1985.tb02351.x","volume":"113","author":"T.P. Chorzelski","year":"1985","unstructured":"Chorzelski, T.P., Jablonska, S., Beutner, E.H. et al. Anticentromere antibody: an immunological marker of a subset of systemic sclerosis. Br J Dermat 1985, 113, 381\u2013389.","journal-title":"Br J Dermat"},{"key":"BF02242937_CR9","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/art.1780310309","volume":"31","author":"E.S. Weiner","year":"1988","unstructured":"Weiner, E.S., Earnshaw, W.C., Sen\u00e9cal, J.L., Bordwell, B., Johnson, P., Rothfield, N.F. Clinical association of anticentromere antibodies and antibodies to topoisomerase I. Arthritis Rheum 1988, 31, 378\u2013385.","journal-title":"Arthritis Rheum"},{"key":"BF02242937_CR10","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/rheumatology\/26.1.17","volume":"26","author":"M.H. Miller","year":"1987","unstructured":"Miller, M.H., Littlejohn, G.D., Davidson, A., Jones, B., Topliss, D.J. The clinical significance of the anticentromere antibody. Br J Rheum 1987, 26, 17\u201321.","journal-title":"Br J Rheum"},{"key":"BF02242937_CR11","first-page":"43","volume":"48","author":"R.M. Bernstein","year":"1982","unstructured":"Bernstein, R.M., Steigerwald, J.C., Tan, E.M. Association of antinuclear antibodies in progressive systemic sclerosis. Clin Exp Immunol 1982, 48, 43\u201351.","journal-title":"Clin Exp Immunol"},{"key":"BF02242937_CR12","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/art.1780270201","volume":"27","author":"H.D. Tramposch","year":"1984","unstructured":"Tramposch, H.D., Smith, C.D., Senecal, J.L., Rothfield, N. A long-term longitudinal study of anticentromere antibodies. Arthritis Rheum 1984, 27, 121\u2013124.","journal-title":"Arthritis Rheum"},{"key":"BF02242937_CR13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1136\/ard.42.1.23","volume":"42","author":"L.J. Catoggio","year":"1983","unstructured":"Catoggio, L.J., Bernstein, R.M., Black, C.M., Hughes, G.R.V., Maddison P.J. Serologic markers in progressive systemic sclerosis. Clinical correlations. Ann Rheum Dis 1983, 42, 23\u201327.","journal-title":"Ann Rheum Dis"},{"key":"BF02242937_CR14","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/art.1780270202","volume":"27","author":"V.D. Steen","year":"1984","unstructured":"Steen, V.D., Ziegler, G.L., Rodnan, G.P., Medsger, T.A. Jr. Clinical and laboratory associations of anticentromere antibody in patients with progressive systemic sclerosis. Arthritis Rheum 1984, 27, 125\u2013131.","journal-title":"Arthritis Rheum"},{"key":"BF02242937_CR15","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1136\/ard.41.4.382","volume":"41","author":"C.G. Kallenberg","year":"1982","unstructured":"Kallenberg, C.G., Pastoor, G.W., Wouda, A.A., The, T.H. Antinuclear antibodies in patients with Raynaud's phenomenon. Clinical significance of anticentromere antibodies. Ann Rheum Dis 1982, 41, 282\u2013287.","journal-title":"Ann Rheum Dis"},{"key":"BF02242937_CR16","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0190-9622(86)70217-X","volume":"15","author":"A. Ruffatti","year":"1986","unstructured":"Ruffatti, A., Peserica, A., Glorioso, S., et al. Anticentromere antibody in localized scleroderma. J Am Acad Dermatol 1986, 15, 637\u2013642.","journal-title":"J Am Acad Dermatol"},{"key":"BF02242937_CR17","first-page":"940","volume":"12","author":"A. Ruffatti","year":"1985","unstructured":"Ruffatti, A., Artifoni, L., Gloriosa, S., et al. Prevalence of anticentromere antibody in blood relatives of anticentromere positive patients. J Rheum 1985, 12, 940\u2013943.","journal-title":"J Rheum"},{"key":"BF02242937_CR18","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1136\/ard.47.8.634","volume":"47","author":"C.G.M. Kallenberg","year":"1988","unstructured":"Kallenberg, C.G.M., Wouda, A.A., Hoet, M.H., Venrooij van, J.V. Development of connective tissue disease in patients presenting with Raynaud's phenomenon: a six-year follow up with emphasis on the predictive value of antinuclear antibodies as detected by immunoblotting. Ann Rheum Dis 1988, 47, 634\u2013641.","journal-title":"Ann Rheum Dis"},{"key":"BF02242937_CR19","first-page":"607","volume":"9","author":"J.R. Seibold","year":"1982","unstructured":"Seibold, J.R., Trontell, M.C. Anticentromere antibody and primary pulmonary hypertension. J Rheumat 1982, 9, 607\u2013609.","journal-title":"J Rheumat"},{"key":"BF02242937_CR20","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1136\/ard.41.6.612","volume":"41","author":"R.M. Bernstein","year":"1982","unstructured":"Bernstein, R.M., Callender, M.E., Neuberger, J.M., Hughes, G.R.V., Williams, R. Anticentromere antibody in primary biliary cirrhosis. Ann Rheum Dis 1982, 41, 612\u2013614.","journal-title":"Ann Rheum Dis"},{"key":"BF02242937_CR21","first-page":"129","volume":"4","author":"V. Modena","year":"1986","unstructured":"Modena, V., Marengo, C., Amoroso, A., et al. Primary biliary cirrhosis and rheumatic diseases: a clinical, immunological and immunogenetical study. Clin Exp Rheum 1986, 4, 129\u2013134.","journal-title":"Clin Exp Rheum"},{"key":"BF02242937_CR22","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1136\/jcp.38.7.801","volume":"38","author":"F. Cassani","year":"1985","unstructured":"Cassani, F., Bianchi, F.B., Lenzi, M., Volta, U., Pisi, E. Immunomorphological characterization of antinuclear antibodies in chronic liver diseases. J Clin Path 1985, 38, 801\u2013805.","journal-title":"J Clin Path"},{"key":"BF02242937_CR23","first-page":"1759","volume":"15","author":"J.P. Wade","year":"1988","unstructured":"Wade, J.P., Sack, B., Schur, P.H. Anticentromere antibodies \u2014 Clinical correlates. J. Rheumatol 1988, 15, 1759\u20131763.","journal-title":"J. Rheumatol"},{"key":"BF02242937_CR24","first-page":"99","volume":"48","author":"G. Haberhauer","year":"1989","unstructured":"Haberhauer, G., Br\u00f6ll, H. Drug-induced anticentromere antibody? Z Rheumatol 1989, 48, 99\u2013100.","journal-title":"Z Rheumatol"},{"key":"BF02242937_CR25","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/art.1780280919","volume":"28","author":"S.R. Mitchell","year":"1985","unstructured":"Mitchell, S.R., McCarty, G.A., Katz, P. Anticentromere antibody is not specific for connective tissue disease with a promising prognosis. Arthritis Rheum, 1985, 28, 1076\u20131077.","journal-title":"Arthritis Rheum"},{"key":"BF02242937_CR26","unstructured":"Medsger, Jr.T.A. Classification of systemic sclerosis. In: Systemic Sclerosis: Scleroderma. Eds.: Jayson MIV and Black CM, John Wiley and Sons LTD 1988, 1\u20136."},{"key":"BF02242937_CR27","doi-asserted-by":"crossref","unstructured":"Masi, A.T., Rodnan, G.P., Medsger, T.A. Jr. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23, 581\u2013590.","DOI":"10.1002\/art.1780230510"},{"key":"BF02242937_CR28","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1002\/art.1780311019","volume":"31","author":"E.M. Tan","year":"1988","unstructured":"ILAR\/IUIS International ANA Committee: Tan, E.M., Feltkamp, T.E.W., Alarcon-Segovia, D., et al. Reference reagents for antinuclear antibodies. Arthritis Rheum 1988, 31, 1331.","journal-title":"Arthritis Rheum"},{"key":"BF02242937_CR29","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/art.1780280114","volume":"28","author":"D.D. Gerbracht","year":"1985","unstructured":"Gerbracht, D.D., Steen, V.D., Ziegler, G.L., Medsger, T.A. Jr., Rodnan, G.P. Evolution of primary Raynaud's phenomenon (Raynaud's disease) to connective tissue disease. Arthritis Rheum 1985, 28, 87\u201392.","journal-title":"Arthritis Rheum"},{"key":"BF02242937_CR30","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/0002-9343(82)90846-4","volume":"72","author":"F.E. Harper","year":"1982","unstructured":"Harper, F.E., Maricq, H.R., Turner, E., Lidman, R.W., Leroy, E.C. A prospective study of Raynaud's phenomenon and early connective tissue disease. Am J Med 1982, 72, 883\u2013888.","journal-title":"Am J Med"},{"key":"BF02242937_CR31","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/0002-9343(87)90647-4","volume":"83","author":"J. Sarkozi","year":"1987","unstructured":"Sarkozi, J., Bookman, A.A., Lee, P., Keystone, E.C., Fritzler, M.J. Significance of anticentromere antibody in idiopathic Raynaud's syndrome. Am J Med 1987, 83, 893\u2013898.","journal-title":"Am J Med"},{"key":"BF02242937_CR32","first-page":"782","volume":"16","author":"W.C. Shiel","year":"1989","unstructured":"Shiel, W.C., Jason, M. The diagnostic associations of patients with antinuclear antibodies referred to a community rheumatologist. J Rheum 1989, 16, 782\u2013785.","journal-title":"J Rheum"},{"key":"BF02242937_CR33","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0889-857X(21)01047-4","volume":"16","author":"G. Reimer","year":"1990","unstructured":"Reimer, G. Autoantibodies against nuclear, nucleolar and mitochondrial antigens in systemic sclerosis (scleroderma). Rheum Dis Clin North Am 1990, 16, 169\u2013183.","journal-title":"Rheum Dis Clin North Am"},{"key":"BF02242937_CR34","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1365-2133.1990.tb08266.x","volume":"122","author":"M. Jarzabek-Chorzelska","year":"1990","unstructured":"Jarzabek-Chorzelska, M., Blaszczyk, M., Kolacinska-Strasz, Z., et al. Are ACA and Scl-70 antibodies mutually exclusive? Br J Derm 1990, 122, 201\u2013208.","journal-title":"Br J Derm"},{"key":"BF02242937_CR35","first-page":"227","volume":"16","author":"A. Ruffatti","year":"1985","unstructured":"Ruffatti, A., Calligaro, A., Ferri, C., et al. Association of anti-centromere and anti-Scl-70 antibodies in scleroderma. Report of two cases. J Clin Lab Immunol 1985, 16, 227\u2013229.","journal-title":"J Clin Lab Immunol"},{"key":"BF02242937_CR36","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/anr.1780320109","volume":"32","author":"L.J. McNeilage","year":"1989","unstructured":"McNeilage, L.J., Youngchaiyud, U., Whittingham, S. Racial differences in antinuclear antibody patterns and clinical manifestations of scleroderma. Arthritis Rheum 1989, 32, 54\u201359.","journal-title":"Arthritis Rheum"},{"key":"BF02242937_CR37","first-page":"1931","volume":"33","author":"R.J. Kipnes","year":"1990","unstructured":"Kipnes, R.J., Craft, J., Hardin, J.A. The analysis of antinuclear and antinucleolar autoantibodies of scleroderma by radioimmunoprecipitation assays. Arthritis Rheum 1990, 33, 1931\u20131936.","journal-title":"Arthritis Rheum"},{"key":"BF02242937_CR38","first-page":"457","volume":"11","author":"M. Hietarinta","year":"1993","unstructured":"Hietarinta, M., Tertti, R., Lassila, O. A patient with systemic sclerosis, severe cytopenias and the simultaneous presence of anticentromere and anti-Scl-70 antibodies. Clin Exp Rheumat 1993, 11, 457\u2013461.","journal-title":"Clin Exp Rheumat"},{"key":"BF02242937_CR39","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1136\/ard.49.11.935","volume":"49","author":"C. Tolosa-Vilella","year":"1990","unstructured":"Tolosa-Vilella, C., Ordi-Ros, J., Vilardell-Tarres, M., Selva-O'Callaghan, Jordana-Comajuncosa, R. Raynaud's phenomenon and positive antinuclear antibodies in a malignancy. Ann Rheum Dis 1990, 49, 935\u2013936.","journal-title":"Ann Rheum Dis"},{"key":"BF02242937_CR40","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1136\/ard.51.4.573-b","volume":"51","author":"M. Zuber","year":"1992","unstructured":"Zuber, M. Positive antinuclear antibodies in malignancies. Ann Rheum Dis 1992, 51, 573\u2013574.","journal-title":"Ann Rheum Dis"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02242937.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02242937\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02242937","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T19:30:30Z","timestamp":1626723030000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02242937"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,9]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1994,9]]}},"alternative-id":["BF02242937"],"URL":"https:\/\/doi.org\/10.1007\/bf02242937","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994,9]]}}}